Tissue culture in genetic engineering and biotechnology

2020 ◽  
pp. 31-41
Author(s):  
D. E. Evans ◽  
J.O.D. Coleman ◽  
A. Kearns
Plants ◽  
2021 ◽  
Vol 10 (10) ◽  
pp. 2078
Author(s):  
Tristan K. Adams ◽  
Nqobile A. Masondo ◽  
Pholoso Malatsi ◽  
Nokwanda P. Makunga

The development of a protocol for the large-scale production of Cannabis and its variants with little to no somaclonal variation or disease for pharmaceutical and for other industrial use has been an emerging area of research. A limited number of protocols have been developed around the world, obtained through a detailed literature search using web-based database searches, e.g., Scopus, Web of Science (WoS) and Google Scholar. This article reviews the advances made in relation to Cannabis tissue culture and micropropagation, such as explant choice and decontamination of explants, direct and indirect organogenesis, rooting, acclimatisation and a few aspects of genetic engineering. Since Cannabis micropropagation systems are fairly new fields, combinations of plant growth regulator experiments are needed to gain insight into the development of direct and indirect organogenesis protocols that are able to undergo the acclimation stage and maintain healthy plants desirable to the Cannabis industry. A post-culture analysis of Cannabis phytochemistry after the acclimatisation stage is lacking in a majority of the reviewed studies, and for in vitro propagation protocols to be accepted by the pharmaceutical industries, phytochemical and possibly pharmacological research need to be undertaken in order to ascertain the integrity of the generated plant material. It is rather difficult to obtain industrially acceptable micropropagation regimes as recalcitrance to the regeneration of in vitro cultured plants remains a major concern and this impedes progress in the application of genetic modification technologies and gene editing tools to be used routinely for the improvement of Cannabis genotypes that are used in various industries globally. In the future, with more reliable plant tissue culture-based propagation that generates true-to-type plants that have known genetic and metabolomic integrity, the use of genetic engineering systems including “omics” technologies such as next-generation sequencing and fast-evolving gene editing tools could be implemented to speed up the identification of novel genes and mechanisms involved in the biosynthesis of Cannabis phytochemicals for large-scale production.


2021 ◽  
pp. 67-83
Author(s):  
N. Manikanda Boopathi ◽  
J. D. Harshith ◽  
V. P. Santhanakrishnan ◽  
M. Raveendran

2016 ◽  
Vol 14 (4) ◽  
pp. 283-302 ◽  
Author(s):  
R. N. Kulkarni ◽  
K. Baskaran ◽  
Tripta Jhang

AbstractPeriwinkle [Catharanthus roseus(L) G. Don] has become one of the very extensively investigated medicinal plants after the discovery of two powerful anti-cancer alkaloids, vinblastine and vincristine, in its leaves more than 50 years ago. These alkaloidal drugs are still in clinical use. Also, periwinkle is still the only source of these alkaloids and their precursors, catharanthine and vindoline. Low concentrations of these alkaloids in the plant and, therefore, high costs of their extraction have led to tremendous efforts towards understanding their biosynthesis and exploration of alternate ways of their production such as, chemical synthesis, cell, tissue and hairy root cultures, and metabolic engineering of heterologous organisms. Literature on this plant is quite voluminous, with an average of about 80 publications per year during last three decades (1985–2015). Nearly 60% of these publications are on physiology, biochemistry, cell and tissue culture, phytochemistry, metabolic and genetic engineering aspects. In spite of these efforts, an economically viable alternative to field-grown periwinkle plants as a source of these alkaloids has not yet been found. Biosynthesis ofC. roseusalkaloids is a complex process involving many genes, enzymes, regulators, inter- and intra-cellular transporters, cell types, organelles and tissues and its current understanding is still considered to be incomplete to produceC. roseusalkaloids through metabolic engineering/synthetic biology. Till such time, breeding periwinkle varieties with higher concentrations of anti-cancer alkaloids for cultivation can be an alternate approach to meet the demand for these alkaloids and reduce their costs. While literature on cell and tissue culture, phytochemistry, metabolic and genetic engineering aspects of periwinkle has been reviewed periodically, crop production and plant breeding aspects have received little attention. In this paper, an attempt has been made to bring together published information on genetics and breeding of periwinkle as a medicinal plant. Some probable constraints which may have hindered taking up periwinkle breeding are identified. Initially, quite a few attempts have been made at genetic improvement of periwinkle through induced polyploidy, and subsequently through induced mutagenesis. Mutations, both natural and induced, provide a valuable resource for use in breeding and in functional and reverse genomics research. It is only during last 6–7 years, genetic diversity has been assessed using molecular markers and very recently molecular markers have been identified for marker-assisted selection for alkaloid yield.


1990 ◽  
Vol 20 (4) ◽  
pp. 452-463 ◽  
Author(s):  
W. M. Cheliak ◽  
D. L. Rogers

Time is a major constraint in the progress of tree improvement programs. Four ways in which time influences the tree improvement process are (i) evolutionary time, (ii) time to harvest, (iii) time to achieve phenotypic stability, and (iv) time to reach reproductive maturity. The ways in which each of these affects the three phases of a tree improvement program (conservation, selection and breeding, and propagation) are identified and discussed. How biotechnological techniques, as well as other enabling technologies, address the time constraint problem is also discussed. The biotechnological approaches include tissue culture, molecular genetics, and genetic engineering; the enabling technologies include early testing and flower induction. Through tissue culture it is possible to increase genetic gain per unit time and increase total genetic gain by using more of the total genetic variation. Development of high-resolution linkage maps, through application of molecular genetics technology, will provide new approaches to early screening, testing, and selection. Additionally, molecular probes will be useful in improving methods that genetically fingerprint germ plasm. Genetic engineering has considerable potential to reduce time constraints. However, because of the diverse breeding and production populations typically employed, much basic work needs to be done to integrate genetically engineered materials into tree improvement programs. Early selection and flower induction address the time constraints imposed by age-stable performance and reproductive maturity. When used in combination with the previously described biotechnologies, a powerful system is created that can dramatically reduce the time required to integrate genetically improved material into forest regeneration programs. An example of integrating tree improvement, clonal forestry, and biotechnology is described for an existing black spruce regeneration program.


Planta Medica ◽  
2006 ◽  
Vol 72 (11) ◽  
Author(s):  
A Ritala ◽  
R Ma ◽  
L Nohynek ◽  
T Suortti ◽  
H Rischer ◽  
...  

1996 ◽  
Vol 72 (1) ◽  
pp. 37-42 ◽  
Author(s):  
Pierre J. Charest

As a general trend, research activities related to biotechnology in the Canadian Forest Service (CFS) have increased significantly during the last decade as illustrated by a marked increase in resources committed to this field and in the number of publications produced by the scientists involved. The three areas covered by CFS biotechnological activities are forest regeneration, forest protection and environmental impact assessment. In forest regeneration, the tissue culture of conifers using somatic embryogenesis is a good example of potential application of biotechnology to conventional tree improvement. This technology is being used on a large scale in British Columbia and involves private firms such as BC Research Inc. Other technologies are also being developed such as genetic engineering which eventually will allow the incorporation of advantageous traits into trees which would otherwise be difficult or impossible to achieve. In forest protection, Bacillus thuringiensis is a well known success of biotechnology. This bacterium is used as a biopesticide in Canada to control spruce budworm and gypsy moth. Its use has been increasing during the last few decades and, with the phasing out of chemical insecticides for forestry use, Bacillus thuringiensis will become one of the few alternatives available for insect control. Insect viruses are also becoming more attractive for the biological control of forest pests. The CFS has registered three viruses for forestry use and the next generation of viruses will be genetically engineered to increase their efficiency and effectiveness. The last area of activity encompasses environmental impact studies of biotechnology products for forestry use. The CFS has been a pioneer in the development of microcosms (soil and aquatic) for studying microbial pesticides used to evaluate the impact of engineered biopesticides. Key words: biotechnology, genetic engineering, biopesticides, molecular biology, tissue culture, microcosm, regulation, environmental impact


Sign in / Sign up

Export Citation Format

Share Document